Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Zhao Hui Zheng"'
Autor:
Ping Zhu, Shi-You Li, Jin Ding, Zhou Fei, Sheng-Nan Sun, Zhao-Hui Zheng, Ding Wei, Jun Jiang, Jin-Lin Miao, San-Zhong Li, Xing Luo, Kui Zhang, Bin Wang, Kun Zhang, Su Pu, Qian-Ting Wang, Xin-Yue Zhang, Gao-Liu Wen, Jun O. Liu, John Thomas August, Huijie Bian, Zhi-Nan Chen, You-Wen He
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 13, Iss 6, Pp 616-624 (2023)
Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines provide a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents may be combined with DC vac
Externí odkaz:
https://doaj.org/article/38ec1a088c2841dabe8481860dfceee9
Autor:
Huijie Bian, Liang Chen, Zhao-Hui Zheng, Xiu-Xuan Sun, Jie-Jie Geng, Ruo Chen, Ke Wang, Xu Yang, Shi-Rui Chen, Si-Yu Chen, Rong-Hua Xie, Kui Zhang, Jin-Lin Miao, Jun-Feng Jia, Hao Tang, Shuang-Shuang Liu, Hong-Wei Shi, Yong Yang, Xiao-Chun Chen, Vinay Malhotra, Nosheen Nasir, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Marcel Berdun Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simon-Campos, Ling Wang, Lin-Na Liu, Qing-Yi Wang, Ding Wei, Zheng Zhang, Zhi-Nan Chen, Ping Zhu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-9 (2023)
Abstract Meplazumab, a humanized CD147 antibody, has shown favourable safety and efficacy in our previous clinical studies. In DEFLECT (NCT04586153), 167 patients with severe COVID-19 were enroled and randomized to receive three dosages of meplazumab
Externí odkaz:
https://doaj.org/article/4930312c464b4f5aab592cc1118df724
Autor:
Jiao Wu, Zhuan Feng, Liang Chen, Yong Li, Huijie Bian, Jiejie Geng, Zhao-Hui Zheng, Xianghui Fu, Zhuo Pei, Yifei Qin, Liu Yang, Yilin Zhao, Ke Wang, Ruo Chen, Qian He, Gang Nan, Xuejun Jiang, Zhi-Nan Chen, Ping Zhu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Expansion of synovial fibroblast is associated with rheumatoid arthritis (RA) progression, but how this expansion is regulated is still not clear. Here the authors use a mouse RA model, single cell RNA sequencing and in vitro analyses to show that in
Externí odkaz:
https://doaj.org/article/30a3aee147db4af3aa058615f826173a
Autor:
Huijie Bian, Zhao-Hui Zheng, Ding Wei, Aidong Wen, Zheng Zhang, Jian-Qi Lian, Wen-Zhen Kang, Chun-Qiu Hao, Jing Wang, Rong-Hua Xie, Ke Dong, Jie-Lai Xia, Jin-Lin Miao, Wen Kang, Guoquan Li, Di Zhang, Mingru Zhang, Xiu-Xuan Sun, Likun Ding, Kui Zhang, Junfeng Jia, Jin Ding, Zhiqin Li, Yanyan Jia, Lin-Na Liu, Zhe Zhang, Zhao-Wei Gao, Hong Du, Na Yao, Qing Wang, Ke Wang, Jie-Jie Geng, Bin Wang, Ting Guo, Ruo Chen, Yu-Meng Zhu, Li-Juan Wang, Qian He, Rui-Rui Yao, Ying Shi, Xiang-Min Yang, Jian-Sheng Zhou, Yi-Nan Ma, Ya-Tao Wang, Xue Liang, Fei Huo, Zhe Wang, Yang Zhang, Xu Yang, Ye Zhang, Lu-Hua Gao, Ling Wang, Xiao-Chun Chen, Hao Tang, Shuang-Shuang Liu, Qing-Yi Wang, Zhi-Nan Chen, Ping Zhu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-11 (2021)
Abstracts Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SARS-CoV-2 replication. Meplazumab
Externí odkaz:
https://doaj.org/article/5eed9c4f8a264dcb9b830636e8b40c7c
Autor:
Yue Zhai, Liang Chen, Qian Zhao, Zhao-Hui Zheng, Zhi-Nan Chen, Huijie Bian, Xu Yang, Huan-Yu Lu, Peng Lin, Xi Chen, Ruo Chen, Hao-Yang Sun, Lin-Ni Fan, Kun Zhang, Bin Wang, Xiu-Xuan Sun, Zhuan Feng, Yu-Meng Zhu, Jian-Sheng Zhou, Shi-Rui Chen, Tao Zhang, Si-Yu Chen, Jun-Jie Chen, Kui Zhang, Yan Wang, Yang Chang, Rui Zhang, Bei Zhang, Li-Juan Wang, Xiao-Min Li, Qian He, Xiang-Min Yang, Gang Nan, Rong-Hua Xie, Liu Yang, Jing-Hua Yang, Ping Zhu
Publikováno v:
Science. 379
Autoimmune diseases such as ankylosing spondylitis (AS) can be driven by emerging neoantigens that disrupt immune tolerance. Here, we developed a workflow to profile posttranslational modifications involved in neoantigen formation. Using mass spectro
Autor:
You-Wen He, Ping Zhu, Sheng-Nan Sun, Jin Ding, Zhao-Hui Zheng, Ding Wei, Jun Jiang, Jin-Lin Miao, San-Zhong Li, Zhou Fei, Kui Zhang, Bin Wang, Kun Zhang, Su Pu, Qian-Ting Wang, Xin-Yue Zhang, Gao-Liu Wen, Shi-You Li, Hui-Jie Bian, Zhi-Nan Chen, Jun Liu
Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines represent a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents including anti-PD-1 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::754155570469c896f348104474828136
https://doi.org/10.21203/rs.3.rs-2199151/v1
https://doi.org/10.21203/rs.3.rs-2199151/v1
Autor:
Jun-Jun Zhang, Gui-Zhen Yu, Zhao-Hui Zheng, Ya-Fei Liu, Yang-Yang Du, Song-Xia Quan, Yu-Jie Liu, Ji-Cheng Lv, Hong Zhang
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175828 (2017)
Chronic kidney disease (CKD) stage 3 was divided into stage G3a and stage G3b in the 2013 Kidney Disease Improving Global Outcomes guidelines. Whether it is appropriate to regard 45 mL/min/per 1.73 m2 as the threshold value of G3a/G3b staging and whe
Externí odkaz:
https://doaj.org/article/e7cd18eeaa0b45bd9da2837074f51f3a
Autor:
Song-Zhi Kong, Ji-Cheng Li, Si-Dong Li, Ming-Neng Liao, Cheng-Peng Li, Pin-Jin Zheng, Min-Hui Guo, Wei-Xiang Tan, Zhao-Hui Zheng, Zhang Hu
Publikováno v:
Marine Drugs, Vol 16, Iss 6, p 181 (2018)
Chitosan oligosaccharide (COS), a natural polysaccharide with good antioxidant and anti-inflammatory properties, is the depolymerized product of chitosan possessing various biological activities. The present study was designed to investigate the poss
Externí odkaz:
https://doaj.org/article/6a54585a81a946a6ba06986b815bdb4e
Publikováno v:
Environmental Disease; Jan-Mar2022, Vol. 7 Issue 1, p22-28, 7p
Autor:
Liao Mingneng, Li Chengpeng, Min-Hui Guo, Pin-Jin Zheng, Zhao-Hui Zheng, Ji-Cheng Li, Zhang Hu, Wei-Xiang Tan, Songzhi Kong, Sidong Li
Publikováno v:
Marine Drugs
Marine Drugs, Vol 16, Iss 6, p 181 (2018)
Marine Drugs; Volume 16; Issue 6; Pages: 181
Marine Drugs, Vol 16, Iss 6, p 181 (2018)
Marine Drugs; Volume 16; Issue 6; Pages: 181
Chitosan oligosaccharide (COS), a natural polysaccharide with good antioxidant and anti-inflammatory properties, is the depolymerized product of chitosan possessing various biological activities. The present study was designed to investigate the poss